Brief: Aligos Therapeutics Inc Files For Offering Of Up To 6.2 Million Common Shares By The Selling Securityholders - SEC Filing
27/03/2025 20:53
March 27 (Reuters) - Aligos Therapeutics Inc ALGS.O: ALIGOS THERAPEUTICS INC FILES FOR OFFERING OF UP TO 6.2 MILLION COMMON SHARES BY THE SELLING SECURITYHOLDERS - SEC FILING Source text: [ID:n0001193125-25-065499] Further company coverage: ALGS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aligos Therapeutics
See all newsUS FDA approves GSK's hepatitis B drug, offering patients chance to stop long-term treatment (updated)
U.S. RESEARCH ROUNDUP-Ciena Corp, Docusign, Snowflake
Brief: Aligos Therapeutics Announces First Participant Dosed In The Phase 1 Study Of Its Potentially Best-In-Class Antisense Oligonucleotide Alg-170675 By Its Partner Amoytop In China
Aligos Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Aligos Therapeutics Q2 net loss narrows on licensing revenue